Cargando…
An Overview on Chemotherapy-induced Cognitive Impairment and Potential Role of Antidepressants
BACKGROUND: Cognitive impairment is an adverse reaction of cancer chemotherapy and is likely to affect up to 75% of patients during the treatment and 35% of patients experience it for several months after the chemotherapy. Patients manifest symptoms like alteration in working ability, awareness, con...
Autores principales: | Das, Ankit, Ranadive, Niraja, Kinra, Manas, Nampoothiri, Madhavan, Arora, Devinder, Mudgal, Jayesh |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Bentham Science Publishers
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7569321/ https://www.ncbi.nlm.nih.gov/pubmed/32091339 http://dx.doi.org/10.2174/1570159X18666200221113842 |
Ejemplares similares
-
Emphasizing the Crosstalk Between Inflammatory and Neural Signaling in Post-traumatic Stress Disorder (PTSD)
por: Govindula, Anusha, et al.
Publicado: (2023) -
Putative involvement of sirtuin modulators in LPS-induced sickness behaviour in mice
por: Kinra, Manas, et al.
Publicado: (2022) -
Neuroprotective effect of Mulmina™ against chemotherapy-induced cognitive decline in normal mice
por: Kinra, Manas, et al.
Publicado: (2021) -
Neuroprotective effect of Mulmina™ against chemotherapy-induced cognitive decline in normal mice
por: Kinra, Manas, et al.
Publicado: (2021) -
Neuroprotective effect of Mulmina Mango against chemotherapy-induced cognitive decline in mouse model of mammary carcinoma
por: John, Jeena, et al.
Publicado: (2022)